Molecular, Neurochemical, and Behavioral Hallmarks of Reserpine as a Model for Parkinson's Disease: New Perspectives to a Long-Standing Model.

Brain Pathology
Anderson H F F LeãoRegina H Silva

Abstract

The administration of reserpine to rodents was one of the first models used to investigate the pathophysiology and screening for potential treatments of Parkinson's disease (PD). The reserpine model was critical to the understanding of the role of monoamine system in the regulation of motor and affective disorders, as well as the efficacy of current PD treatments, such as L-DOPA and dopamine agonists. Nevertheless, with the introduction of toxin-induced and genetic models of PD, reserpine became underused. The main rationale to this drawback was the supposed absence of reserpine construct validity with PD. Here, we highlight classical and recent experimental findings that support the face, pharmacological, and construct validity of reserpine PD model and reason against the current rationale for its underuse. We also aim to shed a new perspective upon the model by discussing the main challenges and potentials for the reserpine model of PD.

References

Nov 26, 1976·Brain Research·O McKennaE Holtzman
Aug 1, 1975·European Journal of Pharmacology·J M GoldsteinJ B Malick
Jan 1, 1992·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·R M Torack, J C Morris
Jan 1, 1990·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·J MajJ Superata
Jan 1, 1989·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·M Carlsson, A Carlsson
Dec 1, 1987·Pharmacology, Biochemistry, and Behavior·R E ChipkinL C Iorio
Feb 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·M B Spina, G Cohen
Jan 1, 1971·Acta Physiologica Scandinavica. Supplementum·U Ungerstedt
Dec 27, 1971·JAMA : the Journal of the American Medical Association·T L Sourkes
May 1, 1971·British Journal of Pharmacology·G R Breese, T D Traylor
Apr 1, 1982·Archives of General Psychiatry·J M Kane, J M Smith
Apr 30, 1984·Biochemical and Biophysical Research Communications·K ChibaN Castagnoli
Jun 1, 1983·Brain : a Journal of Neurology·A J Lees, E Smith
Jan 1, 1994·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·W DanyszG Quack
Jan 1, 1994·Journal of Neural Transmission. General Section·G SkuzaW Danysz
Oct 1, 1993·Pharmacology, Biochemistry, and Behavior·R E Steinpreis, J D Salamone
May 1, 1993·Neurology·R M ZweigJ C Hedreen
May 23, 1996·European Journal of Pharmacology·S Kaur, M Starr
Jan 1, 1996·Pharmacology, Biochemistry, and Behavior·J Salamone, P Baskin
Nov 1, 1996·Biological & Pharmaceutical Bulletin·M MiyagiM Isaji
Apr 11, 1997·European Journal of Pharmacology·J MajK Kołodziejczyk
Feb 14, 1998·Neurobiology of Aging·M BergamoR Frussa-Filho
Jun 24, 1998·Proceedings of the National Academy of Sciences of the United States of America·J AraH Ischiropoulos
Feb 23, 2000·Pharmacology, Biochemistry, and Behavior·K FukuzakiR Nagata
Dec 2, 2000·Nature Neuroscience·R BetarbetJ T Greenamyre
May 2, 2001·Nature Reviews. Neuroscience·M F Beal

❮ Previous
Next ❯

Citations

Jul 26, 2016·Frontiers in Neuroscience·Pollyana C LealJosé R Santos
May 16, 2015·Biochemical and Biophysical Research Communications·Kang Il LeeJunsoo Park
Oct 14, 2016·Frontiers in Pharmacology·Fernanda F PeresVanessa C Abílio
Sep 7, 2019·Molecular Neurodegeneration·Anna MasatoLuigi Bubacco
Aug 25, 2017·Evidence-based Complementary and Alternative Medicine : ECAM·Luiz Eduardo Mateus BrandãoAlessandra Mussi Ribeiro
Oct 20, 2017·Frontiers in Pharmacology·Caio M MassariFrancisco Ciruela
Jan 1, 2019·Journal of Chemical Neuroanatomy·Pollyana C LealJosé R Santos
Mar 26, 2021·Neurotoxicity Research·Mohamed El-GamalAhmed A Moustafa
May 1, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Kinga Sałat, Anna Furgała-Wojas
May 22, 2021·Journal of Thermal Biology·Nadezhda M ZakharovaAnatoly L Kovtun
Jul 22, 2021·Archives of Pharmacal Research·Eun-Joo ShinHyoung-Chun Kim
Nov 28, 2018·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Jose I A Beserra-FilhoAlessandra M Ribeiro
Aug 6, 2021·Clinical and Experimental Pharmacology & Physiology·Suellen Silva-MartinsAlessandra Mussi Ribeiro

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

California Medicine
F H McDowell, J E Lee
L'unión médicale du Canada
A Barbeau
Canadian Medical Association Journal
R A Cleghorn
© 2022 Meta ULC. All rights reserved